Hydrogel microchip as a tool for studying exosomes in human serum
- Autores: Butvilovskaya V.I.1, Tikhonov A.A.1, Savvateeva E.N.1, Ragimov A.A.2, Salimov E.L.2, Voloshin S.A.1, Sidorov D.V.3, Chernichenko M.A.3, Polyakov A.P.3, Filushin M.M.3, Tsybulskaya M.V.1, Rubina A.Y.1
-
Afiliações:
- Engelhardt Institute of Molecular Biology
- Sechenov First Moscow State Medical University
- Herzen Moscow Cancer Research Institute
- Edição: Volume 51, Nº 5 (2017)
- Páginas: 712-717
- Seção: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163239
- DOI: https://doi.org/10.1134/S0026893317050053
- ID: 163239
Citar
Resumo
Exosomes are cell-derived vesicles that are secreted by both normal and cancer cells. Over the last decade, a few studies have revealed that exosomes cross talk and/or influence major tumor-related pathways such as angiogenesis and metastasis involving many cell types within the tumor microenvironment. The protein composition of the membrane of an exosome reflects that of the membrane of the cell of origin. Because of this, tumor-derived exosomes differ from exosomes that are derived from normal cells. The detection of tumor exosomes and analysis of their molecular composition hold promise for diagnosis and prognosis of cancer. Here, we present hydrogel microarrays (biochips), which contain a panel of immobilized antibodies that recognize tetraspanins (CD9, CD63, CD81) and prognostic markers for colorectal cancer (A33, CD147). These biochips make it possible to analyze the surface proteins of either isolated exosomes or exosomes that are present in the serum samples without isolation. These biochips were successfully used to analyze the surface proteins of exosomes from serum that was collected from a colorectal cancer patient and healthy donor. Biochip-guided immunofluorescent analysis of the exosomes has made it possible for us to detect the A33 antigen and CD147 in the serum sample of the colorectal cancer patient with normal levels of CEA and CA19-9.
Palavras-chave
Sobre autores
V. Butvilovskaya
Engelhardt Institute of Molecular Biology
Autor responsável pela correspondência
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
A. Tikhonov
Engelhardt Institute of Molecular Biology
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
E. Savvateeva
Engelhardt Institute of Molecular Biology
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
A. Ragimov
Sechenov First Moscow State Medical University
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
E. Salimov
Sechenov First Moscow State Medical University
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
S. Voloshin
Engelhardt Institute of Molecular Biology
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
D. Sidorov
Herzen Moscow Cancer Research Institute
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 125284
M. Chernichenko
Herzen Moscow Cancer Research Institute
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 125284
A. Polyakov
Herzen Moscow Cancer Research Institute
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 125284
M. Filushin
Herzen Moscow Cancer Research Institute
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 125284
M. Tsybulskaya
Engelhardt Institute of Molecular Biology
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
A. Rubina
Engelhardt Institute of Molecular Biology
Email: v.butvilovskaya@gmail.com
Rússia, Moscow, 119991
Arquivos suplementares
